You are here:

posaconazole 40mg/ml oral suspension (Noxafil)


Following a full submission

posaconazole (Noxafil®) is accepted for restricted use within NHS Scotland for prophylaxis of invasive fungal infections in immunocompromised patients. It is restricted to patients in whom there is a specific risk of Aspergillus infection or where fluconazole or itraconazole are not tolerated.

Drug Details

Drug Name: posaconazole 40mg/ml oral suspension (Noxafil)
SMC Drug ID: 379/07
Manufacturer: Schering-Plough Ltd
Indication: Prophylaxis of invasive fungal infections
BNF Category:
Sub Category: 5.2 Antifungal Drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 11 June 2007